Advanced search

Comparative genomic hybridization (CGH) analysis of stage 4 neuroblastoma reveals high frequency of 11Q deletion in tumors lacking MYCN amplification.

Author
Organization

Citation

Please use this url to cite or link to this publication:

Chicago
PLANTAZ, D, Jo Vandesompele, Nadine Van Roy, M LASTOWSKA, N BOWN, V COMBARET, MC FAVROT, et al. 2001. “Comparative Genomic Hybridization (CGH) Analysis of Stage 4 Neuroblastoma Reveals High Frequency of 11Q Deletion in Tumors Lacking MYCN Amplification.” International Journal of Cancer 91 (5): 680–686.
APA
PLANTAZ, D., Vandesompele, J., Van Roy, N., LASTOWSKA, M., BOWN, N., COMBARET, V., FAVROT, M., et al. (2001). Comparative genomic hybridization (CGH) analysis of stage 4 neuroblastoma reveals high frequency of 11Q deletion in tumors lacking MYCN amplification. INTERNATIONAL JOURNAL OF CANCER, 91(5), 680–686.
Vancouver
1.
PLANTAZ D, Vandesompele J, Van Roy N, LASTOWSKA M, BOWN N, COMBARET V, et al. Comparative genomic hybridization (CGH) analysis of stage 4 neuroblastoma reveals high frequency of 11Q deletion in tumors lacking MYCN amplification. INTERNATIONAL JOURNAL OF CANCER. 2001;91(5):680–6.
MLA
PLANTAZ, D, Jo Vandesompele, Nadine Van Roy, et al. “Comparative Genomic Hybridization (CGH) Analysis of Stage 4 Neuroblastoma Reveals High Frequency of 11Q Deletion in Tumors Lacking MYCN Amplification.” INTERNATIONAL JOURNAL OF CANCER 91.5 (2001): 680–686. Print.
@article{141122,
  author       = {PLANTAZ, D and Vandesompele, Jo and Van Roy, Nadine and LASTOWSKA, M and BOWN, N and COMBARET, V and FAVROT, MC and DELATTRE, O and MICHON, J and BENARD, J and HARTMANN, O and NICHOLSON, JC and ROSS, FM and BRINKSCHMIDT, C and Laureys, Genevieve and CARON, H and MATTHAY, KK and FEUERSTEIN, BG and Speleman, Franki},
  issn         = {0020-7136},
  journal      = {INTERNATIONAL JOURNAL OF CANCER},
  language     = {eng},
  number       = {5},
  pages        = {680--686},
  title        = {Comparative genomic hybridization (CGH) analysis of stage 4 neuroblastoma reveals high frequency of 11Q deletion in tumors lacking MYCN amplification.},
  volume       = {91},
  year         = {2001},
}

Web of Science
Times cited: